Tuesday, February 28, 2006


BioCryst Reports Fourth Quarter and Year-End 2005 Financial Results (Hep C Chronic Fatigue)


BioCryst Reports Fourth Quarter and Year-End 2005 Financial Results
dBusinessNews.com - Offering comprehensive Web design services to new economy enterprises across a wide range of platforms and technologies, Web Design Studio takes pride in delivering big-business Internet solutions to small and medium-sized businesses. BIRMINGHAM

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial
Medical News Today - GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques